Cargando…
Downregulation of microRNA-605 indicates poor prognosis and promotes the progression of osteosarcoma
Osteosarcoma (OS) is a type of primary bone tumor, which is one of the leading causes of cancer-related death. MicroRNA (miR)-605 has been demonstrated to act as a prognostic biomarker and therapeutic target in various cancers, such as breast cancer and non-small cell lung cancer, but its function i...
Autores principales: | Yi, Xiuling, Liu, Chunlei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608056/ https://www.ncbi.nlm.nih.gov/pubmed/33154768 http://dx.doi.org/10.3892/ol.2020.12233 |
Ejemplares similares
-
MicroRNA-145 downregulation associates with advanced tumor progression and poor prognosis in patients suffering osteosarcoma
por: Tang, Mingjie, et al.
Publicado: (2013) -
Downregulation of microRNA-132 indicates progression in hepatocellular carcinoma
por: Zhang, Xin, et al.
Publicado: (2016) -
MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis
por: Sakamoto, Naoya, et al.
Publicado: (2014) -
microRNA-544 promoted human osteosarcoma cell proliferation by downregulating AXIN2 expression
por: Chen, Ming, et al.
Publicado: (2018) -
MicroRNA-124 functions as a tumor suppressor and indicates prognosis in human osteosarcoma
por: HAN, GANG, et al.
Publicado: (2015)